RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer's Disease pathology.
RetiSpec has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in July 2024.
RetiSpec's investors include Eli Lilly, iGan Partners, MassChallenge, University of Minnesota, Center of Aging and Brain Health Innovation.
RetiSpec is headquartered in Toronto, Canada.
RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer's Disease pathology.
RetiSpec is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RetiSpec — Funding & Investors." VCBacked, July 26, 2024, https://www.vcbacked.co/company/retispec. Accessed October 17, 2026.
VCBacked. (2024). RetiSpec — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/retispec
{{cite web |title=RetiSpec — Funding & Investors |url=https://www.vcbacked.co/company/retispec |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated